GOSSAMER BIO INC (GOSS)
US38341P1021 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 32.11M | 112.00M | 183.40M | 486.10M | 135.10M | |||
| Marketable Securities | 264.32M | 143.70M | 141.80M | 26.60M | 266.70M | |||
| Other Current Assets | 10.09M | 6.20M | 6.60M | 9.70M | 7.50M | |||
| Total Current Assets | 306.52M | 261.90M | 331.80M | 522.30M | 409.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.78M | 9.90M | 10.80M | 16.10M | 15.70M | |||
| Other Non-Current Assets | 618.00K | 700.00K | 1.10M | 1.00M | 1.60M | |||
| Total Non-Current Assets | 5.40M | 10.60M | 11.90M | 17.10M | 17.30M | |||
| TOTAL ASSETS | 311.92M | 272.50M | 343.70M | 539.40M | 426.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.61M | 11.60M | N/A | N/A | N/A | |||
| Accrued Expenses | 34.46M | 36.20M | 36.60M | 31.10M | 36.00M | |||
| Accounts Payable | 5.53M | 1.50M | 3.20M | 7.50M | 1.00M | |||
| Total Current Liabilities | 51.60M | 49.20M | 39.90M | 38.70M | 36.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 197.41M | 207.70M | 179.10M | 172.40M | 28.50M | |||
| Other Non-Current Liabilities | 144.00K | 3.40M | 3.20M | 7.70M | 8.70M | |||
| Total Non-Current Liabilities | 197.55M | 211.20M | 182.30M | 180.00M | 37.20M | |||
| TOTAL LIABILITIES | 249.15M | 260.40M | 222.20M | 218.70M | 74.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.21B | -1.03B | -811.50M | -577.50M | -334.20M | |||
| Additional Paid In Capital | 1.28B | 1.04B | 932.90M | 897.60M | 686.40M | |||
| Common Shares | 23.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -350.00K | -600.00K | 0.00 | 600.00K | 300.00K | |||
| Shares Outstanding | 225.41M | 94.40M | 75.80M | 73.90M | 61.60M | |||
| Tangible Book Value per Share | 0.28 | 0.13 | 1.60 | 4.34 | 5.72 | |||
| Total Shareholders' Equity | 62.77M | 12.10M | 121.50M | 320.70M | 352.50M | |||
| TOTAL LIABILITIES AND EQUITY | 311.92M | 272.50M | 343.70M | 539.40M | 426.60M | |||
| Statistics | ||||||||
| Debt/Equity | 3.14 | 17.17 | 1.47 | 0.54 | 0.08 | |||
| Current Ratio | 5.94 | 5.32 | 8.32 | 13.50 | 11.09 | |||
| Return On Assets (ROA) | -57.65% | -84.18% | -68.08% | -45.12% | -42.27% | |||
| Return On Equity (ROE) | -286.47% | -1895.70% | -192.59% | -75.88% | -51.15% | |||
All data in USD